<h1 itemprop="aspect"> <strong>Gabitril Side Effects</strong></h1><div class="thumbnail-div"> <img width="84" height="84" src="http://www.bad-drug.net/wp-content/uploads/2013/02/gabitril-84x84.jpg?1df917" class="attachment-84x84 wp-post-image" alt="Gabitril" title="Gabitril" pagespeed_url_hash="3807825885" onload="pagespeed.CriticalImages.checkImageForCriticality(this);"/></div><h1>Serious Adverse Side Effects</h1><ul><li>Dermatological side effects such as Stevens-Johnson syndrome, a deadly allergic skin reaction to the drug</li><li>Neurological side effects such as seizures in patients without epilepsy and status epilepticus, a disorder in which the brain is in permanent seizure</li><li>Psychiatric side effects such as suicidal thoughts</li><li>Other side effects such as overdose and death</li></ul><h2>Common Adverse Side Effects</h2><ul><li>Dermatological side effects such as itching</li><li>Gastrointestinal side effects such as abdominal pain and nausea</li><li>Neurological side effects such as weakness, lack of coordination, confusion, disturbance in speech, dizziness, anxiety, insomnia, drowsiness, tremor and inability to concentrate</li><li>Respiratory side effects such as inflammation of the throat</li></ul></div><div class="v" id="tab2" ><h2 itemprop="aspect"> <strong> Warnings & Recalls for Gabitril </strong></h2><h2>Contraindications</h2> The only known contraindication of <b>Gabitril </b><b>| </b><b>Tiagabine</b><b> </b>is a hypersensitivity to its active component of Tiagabine.<h2>Precautions</h2> The following patients must exercise caution while taking <b>Gabitril </b><b>| </b><b>Tiagabine</b>:<ul><li>Patients taking this drug must be cautious while operating a vehicle or machinery</li><li>There must be gradual withdrawal from this drug</li><li>Patients with EEG dysfunctions</li><li>Patients with a history of liver disease</li><li>Patients with a history of suicidal thoughts are advised to abstain from this drug</li></ul><h2>Pregnancy Warning</h2> <b>Gabitril </b><b>| </b><b>Tiagabine</b><b> </b>has been given a pregnancy category rating of “C” by the FDA, entailing although it doesn’t pose that much of a risk to the fetus or the expecting mother, it should probably be avoided at all costs during pregnancy.</div><div class="v" id="tab3" ><h2 itemprop="aspect"> <strong> Gabitril Treatment and Use </strong></h2><div class="thumbnail-div"> <img width="84" height="84" src="http://www.bad-drug.net/wp-content/uploads/2013/02/gabitril-84x84.jpg?1df917" class="attachment-84x84 wp-post-image" alt="Gabitril" title="Gabitril" pagespeed_url_hash="3807825885" onload="pagespeed.CriticalImages.checkImageForCriticality(this);"/></div><p><b>Gabitril </b><b>| </b><b>Tiagabine</b><b> </b>is an <a target="_blank" href="http:/en.wikipedia.org/wiki/Anticonvulsant" target="_blank" rel="nofollow">anticonvulsant</a> prescription produced by the drug company <a target="_blank" href="http:/www.cephalon.com/" target="_blank" rel="nofollow">Cephalon</a>. The drug was originally manufactured by <a target="_blank" href="http:/www.novonordisk.com/" target="_blank" rel="nofollow">Novo Nordisk</a> in the nation of Denmark in 1988 by a team of pharmacologists and chemists.  The drug <b>Tiagabine</b> was developed with the drug company <a target="_blank" href="http:/www.abbott.com/index.htm" target="_blank" rel="nofollow">Abbott</a>, in a 40:60 ratio cost sharing deal with Abbott paying premiums for licensing the drug from Novo Nordisk.  After a period of cooperation, the drug is now exclusively licensed, manufactured and marketed by Cephalon currently.</p><p>The official FDA-labeled indications for <b>Gabitril </b><b>| </b><b>Tiagabine</b><b> </b>is for <a target="_blank" href="http:/www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001714/" target="_blank" rel="nofollow">seizure</a>.  Other non-FDA labeled indications for this drug are for <a target="_blank" href="http:/www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001915/" target="_blank" rel="nofollow">generalized anxiety disorder</a> and <a target="_blank" href="http:/en.wikipedia.org/wiki/Spasticity" target="_blank" rel="nofollow">spasticity</a>.</p><h2>How This Drug Works</h2><p><b>Gabitril </b><b>| </b><b>Tiagabine</b><b> </b>is an antiepileptic agent which is thought to enhance the activities of inhibitory neurotransmitter gamma aminobutyric acid (GABA) by blocking this acid’s uptake into presynaptic neurons.  This activity in turn provides more GABA to bind to receptors on post-synaptic cells.</p><h2>Dosage Information</h2><p>The safety and the efficacy of using <b>Gabitril </b><b>| </b><b>Tiagabine</b><b> </b>on pediatric patients under the age of 12 has as of yet not been established.  <b>Gabitril </b><b>| </b><b>Tiagabine</b><b> </b>is taken orally and should always be taken with food.</p><ul><li>In pediatric patients from the ages of 12-18, <b>Gabitril </b><b>| </b><b>Tiagabine</b><b> </b>should be initiated at 4mg once daily.  The total dose of this drug in these patients can be increased by 4mg at the 2<sup>nd</sup> week of taking this medication.  The maximum daily dose on such patients should not exceed 32mg/day given up to 2-4 times daily.</li><li>In adult patients, <b>Gabitril </b><b>| </b><b>Tiagabine</b><b> </b>should be initiated at 4mg once daily and daily doses can be increased by 4-8mg at weekly intervals until the maximum dosage of 56mg/day is achieved given in divided doses of 2-4 times daily.</li></ul></div><div class="v" id="tab4" ><h2 itemprop="aspect"> Other Names for Gabitril</h2><h2>Brand Name</h2><br/><ul><br/><li>Gabitril</li><br/></ul><br/><h2>Generic Name</h2><br/><ul><br/><li>Tiagabine</li><br/></ul></div><div class="v" id="tab5" ><h2 itemprop="aspect"> <strong> Lawsuits & Legal Information for Gabitril </strong></h2>